UNSPSC 51434908: Amlodipine/hydrochlorothiazide/valsartan

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434908 Amlodipine/hydrochlorothiazide/valsartan is a Commodity code under which state and local governments procure specific pharmaceutical products, both branded formulations and generic equivalents, for use in emergency medical services, health systems, and pharmacy benefit programs. State and local buyers under this code include municipal fire and rescue departments, state health agencies, and multistate cooperative purchasing alliances that aggregate demand across participating jurisdictions. The scope of work covers the supply of finished pharmaceuticals meeting FDA requirements, cGMP certification, and Drug Supply Chain Security Act compliance, with vendors required to maintain expiration-date guarantees (typically nine months to one year from delivery), arrange logistics and replacement of expired stock, and provide comprehensive safety documentation including Safety Data Sheets and accessibility conformance reports where applicable.

Recent activity spans Florida, Texas, and Minnesota, with representatives including the City of Tampa's Purchasing Department soliciting Advanced Life Support Medications (IFB 26P00188, due April 8, 2026, estimated contract value $40,000) for Tampa Fire Rescue; the Texas Health and Human Services Commission issuing an RFI (HHS0017013, posted April 3, 2026) to evaluate vendor capabilities for direct-to-manufacturer prescription fulfillment outside traditional pharmacy benefit manager and group purchasing organization channels; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administering an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers to state and local government facilities across multiple participating states including Oregon. Vendors pursuing opportunities under this code should expect to meet stringent supply-chain security, insurance, and product-quality requirements, demonstrate pricing flexibility across multiple pricing models, and maintain relationships with established pharmaceutical wholesalers where required by the purchasing entity.